BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6174729)

  • 1. Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
    Bacopoulos NG; Bustos G; Redmond DE; Roth RH
    J Pharmacol Exp Ther; 1982 Apr; 221(1):22-8. PubMed ID: 6174729
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine.
    Bacopoulos NG; Redmond DE; Roth RH
    J Neurochem; 1979 Apr; 32(4):1215-8. PubMed ID: 107277
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic haloperidol or fluphenazine: effects on dopamine metabolism in brain, cerebrospinal fluid and plasma of Cercopithecus aethiops (vervet monkey).
    Bacopoulos NG; Redmond DE; Baulu J; Roth RH
    J Pharmacol Exp Ther; 1980 Jan; 212(1):1-5. PubMed ID: 6766186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional sensitivity of primate brain dopaminergic neurons to haloperidol: alterations following chronic treatment.
    Bacopoulos NG; Bustos G; Redmond DE; Baulu J; Roth RH
    Brain Res; 1978 Nov; 157(2):396-401. PubMed ID: 31230
    [No Abstract]   [Full Text] [Related]  

  • 5. [Increased tolerance of the dopamine- and serotoninergic systems during chronic administration of haloperidol and levomepromazine].
    Allikmets LKh; Zharkovskiĭ AM; Otter MIa; Khinrikus TKh
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1979; 29(5):1067-70. PubMed ID: 573939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of microinjections of apamin into the A10 dopamine region of rats: a behavioral and neurochemical analysis.
    Steketee JD; Kalivas PW
    J Pharmacol Exp Ther; 1990 Aug; 254(2):711-9. PubMed ID: 1696632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
    Henderson MG; McMillen BA
    Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate and "day-after" effects of morphine on dopamine and serotonin metabolism in various structures of the rat brain.
    Antkiewicz-Michaluk L; Romańska I; Vetulani J
    Pol J Pharmacol; 1995; 47(4):355-8. PubMed ID: 8616517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial attenuation of chronic fluphenazine-induced changes in regional monoamine metabolism by D-alpha-tocopherol in rat brain.
    Jackson-Lewis V; Przedborski S; Kostic V; Suber F; Fahn S; Cadet JL
    Brain Res Bull; 1991 Feb; 26(2):251-8. PubMed ID: 1707329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Haleem DJ; Batool F; Khan NH; Kamil N; Ali O; Saify ZS; Haleem MA
    Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of dopamine metabolism in rat brain, assessed by the influence of drugs [proceedings].
    Dedek J; Gomeni R; Korf J
    Arch Int Physiol Biochim; 1979 Oct; 87(4):794-5. PubMed ID: 93908
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of L-tyrosine on brain monoamines in rats given intravenous amphetamine.
    Smith DG; Geis LS; Lyness WH
    Subst Alcohol Actions Misuse; 1984-1985; 5(6):293-8. PubMed ID: 6085821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical estimations of some new quaternary phenacyl-bromopiperidinium compounds.
    Akhtar S; Saify ZS; Arif M; Mushtaq N; Haleem DJ
    Pak J Pharm Sci; 2005 Apr; 18(2):52-4. PubMed ID: 16431400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.
    Wheeler SC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):151-9. PubMed ID: 7190650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sub-chronic nandrolone decanoate treatment on dopaminergic and serotonergic neuronal systems in the brains of rats.
    Kurling S; Kankaanpää A; Ellermaa S; Karila T; Seppälä T
    Brain Res; 2005 May; 1044(1):67-75. PubMed ID: 15862791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of U and 137Cs chronic contamination on dopamine and serotonin metabolism in the central nervous system of the rat.
    Houpert P; Lestaevel P; Amourette C; Dhieux B; Bussy C; Paquet F
    Can J Physiol Pharmacol; 2004 Feb; 82(2):161-6. PubMed ID: 15052298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration.
    Kurachi M; Shibata R; Murata M; Tanii Y
    Biol Psychiatry; 1995 Apr; 37(7):487-90. PubMed ID: 7786966
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced haloperidol: effects on striatal dopamine metabolism and conversion to haloperidol in the rat.
    Korpi ER; Wyatt RJ
    Psychopharmacology (Berl); 1984; 83(1):34-7. PubMed ID: 6204352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic antidepressants.
    Keller HH; Burkard WP; Da Prada M
    Adv Biochem Psychopharmacol; 1980; 24():175-9. PubMed ID: 6157309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.